PL315635A1 - Method of solubilising hardly pharmaceutically active substances - Google Patents

Method of solubilising hardly pharmaceutically active substances

Info

Publication number
PL315635A1
PL315635A1 PL95315635A PL31563595A PL315635A1 PL 315635 A1 PL315635 A1 PL 315635A1 PL 95315635 A PL95315635 A PL 95315635A PL 31563595 A PL31563595 A PL 31563595A PL 315635 A1 PL315635 A1 PL 315635A1
Authority
PL
Poland
Prior art keywords
solubilising
hardly
active substances
pharmaceutically active
pharmaceutically
Prior art date
Application number
PL95315635A
Inventor
Dadi Jamshed Dhabhar
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PL315635A1 publication Critical patent/PL315635A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL95315635A 1994-01-24 1995-01-24 Method of solubilising hardly pharmaceutically active substances PL315635A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18557694A 1994-01-24 1994-01-24
PCT/US1995/001018 WO1995019759A1 (en) 1994-01-24 1995-01-24 Process for solubilizing difficultly soluble pharmaceutical actives

Publications (1)

Publication Number Publication Date
PL315635A1 true PL315635A1 (en) 1996-11-25

Family

ID=22681571

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95315635A PL315635A1 (en) 1994-01-24 1995-01-24 Method of solubilising hardly pharmaceutically active substances

Country Status (14)

Country Link
EP (1) EP0741560A1 (en)
JP (1) JPH09508128A (en)
CN (1) CN1138827A (en)
AU (1) AU706890B2 (en)
BR (1) BR9506564A (en)
CA (1) CA2181241C (en)
CZ (1) CZ210496A3 (en)
FI (1) FI962948L (en)
MX (1) MX9602955A (en)
NO (1) NO963052L (en)
NZ (1) NZ279443A (en)
PL (1) PL315635A1 (en)
SK (1) SK96196A3 (en)
WO (1) WO1995019759A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA975444B (en) * 1996-06-20 1998-12-21 Mcneil Ppc Inc Acetaminophen and meclizine hydrochloride analgesics
WO1998058637A1 (en) * 1996-06-20 1998-12-30 Mcneil-Ppc Acetaminophen and diphenhydramine analgesics
FR2751875B1 (en) * 1996-08-05 1998-12-24 Scr Newpharm NOVEL STABLE LIQUID FORMULATIONS BASED ON PARACETAMOL AND THEIR METHOD OF PREPARATION
US5763449A (en) * 1996-08-07 1998-06-09 Ascent Pediatrics, Inc. Pleasant-tasting aqueous liquid composition of a bitter-tasting drug
AU2117399A (en) * 1998-01-20 1999-08-02 Applied Analytical Industries, Inc. Oral liquid compositions
US6365180B1 (en) * 1998-01-20 2002-04-02 Glenn A. Meyer Oral liquid compositions
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
US20020082307A1 (en) * 1999-01-11 2002-06-27 Dobrozsi Douglas Joseph Compositions having improved stability
US20020086878A1 (en) * 1999-01-11 2002-07-04 Douglas Joseph Dobrozsi Compositions having improved stability
US6211246B1 (en) 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
FR2796843B1 (en) * 1999-07-29 2003-05-09 So Ge Val Sa CONCENTRATED AND STABILIZED ANTIPYRETIC COMPOSITION FOR VETERINARY USE INTENDED TO BE INCORPORATED IN ANIMAL FEEDING AS WELL AS A METHOD OF INCORPORATING THIS COMPOSITION INTO ANIMAL BEVERAGE WATER
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
DE10011032A1 (en) * 2000-03-07 2001-09-13 Bayer Ag Stable solutions of acetylsalicylic acid in mixture of organic solvent and water, useful for topical treatment of pain, especially pain associated with herpes zoster
KR20020069387A (en) * 2001-02-26 2002-09-04 진양제약주식회사 Mixing method of composition containing doxylamine succinate and soft capsule preparation containing the composition
BR0211794A (en) * 2001-07-31 2004-11-03 Wyeth Corp Pharmaceutical composition and method for masking the taste of at least one unpleasant tasting pharmaceutically active compound
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
CN100379406C (en) * 2003-09-22 2008-04-09 北京德众万全药物技术开发有限公司 Method for preparing tiny pellets of difficult soluble drugs and formulation containing the pellets
JP5406530B2 (en) * 2005-10-26 2014-02-05 バナー ファーマキャプス， インコーポレイテッド Dual controlled release matrix system based on hydrophilic vehicle
DE102005053066A1 (en) 2005-11-04 2007-05-10 Basf Ag Use of copolymers as solubilizers for sparingly water-soluble compounds
EP1962908A2 (en) * 2005-12-09 2008-09-03 Basf Se Use of polyvinyl lactam-polyoxyalkylene block copolymers as solubilisers for poorly water-soluble compounds
US8637076B2 (en) 2006-06-01 2014-01-28 Cima Labs Inc. Prednisolone salt formulations
JP2008184430A (en) * 2007-01-30 2008-08-14 Ss Pharmaceut Co Ltd Soft capsule
CA2690488C (en) * 2010-01-19 2013-06-11 Accucaps Industries Limited Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
RS62327B1 (en) 2010-01-28 2021-10-29 Eagle Pharmaceuticals Inc Formulations of bendamustine
HRP20240056T1 (en) 2012-03-20 2024-03-29 Eagle Pharmaceuticals, Inc. Formulations of bendamustine
JP6224064B2 (en) 2012-03-20 2017-11-01 イーグル・ファーマシューティカルズ・インコーポレーテッド Method for treating bendamustine responsive symptoms in patients in need of reduced dose volume
MX345183B (en) 2013-02-28 2017-01-05 Pfizer Enhanced stability of novel liquid compositions.
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
TWI586379B (en) 2015-06-29 2017-06-11 永信藥品工業股份有限公司 Method of preparing very slightly soluble drug with solid dosage form
CA3001337C (en) 2015-10-09 2023-12-12 Reckitt Benckiser Llc Pharmaceutical formulation
CN115957194B (en) * 2021-10-08 2025-05-16 人福普克药业（武汉）有限公司 Solvent system for content in cold soft capsule and cold soft capsule

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives

Also Published As

Publication number Publication date
NO963052L (en) 1996-09-24
EP0741560A1 (en) 1996-11-13
BR9506564A (en) 1997-09-02
CZ210496A3 (en) 1996-12-11
FI962948A0 (en) 1996-07-23
AU706890B2 (en) 1999-07-01
MX9602955A (en) 1997-06-28
FI962948A7 (en) 1996-07-23
SK96196A3 (en) 1997-03-05
WO1995019759A1 (en) 1995-07-27
CN1138827A (en) 1996-12-25
AU1607595A (en) 1995-08-08
NZ279443A (en) 1998-04-27
FI962948L (en) 1996-07-23
CA2181241A1 (en) 1995-07-27
JPH09508128A (en) 1997-08-19
CA2181241C (en) 2000-04-25
NO963052D0 (en) 1996-07-22

Similar Documents

Publication Publication Date Title
PL315635A1 (en) Method of solubilising hardly pharmaceutically active substances
GB9711208D0 (en) Therapeutic structure and method
HUP0000808A3 (en) Pharmaceutical composition of fenofibrate and method for preparing same
AP2000001783A0 (en) Disinfectant and method of making
AU6564398A (en) Wagering system and method of wagering
PL336693A1 (en) Novel method of obtaining farmacologically active substances
EP0863748A4 (en) Liposomal compositions and methods of using them
AU5961598A (en) Pari-mutuel gaming system and method of using same
AU2502395A (en) Battery-actuated insecticide transpirator and method for transpirating insecticide
HU9401580D0 (en) Method for the preparation and popification of alphia - interferon
AUPN698495A0 (en) Improved therapeutic formulation and method
AU1970495A (en) Drug delivery device and method of construction
GB2312406B (en) One-piece end support and method of forming thereof
ZA967654B (en) Electrodes and methods of preparation thereof
AUPO727097A0 (en) Method of treatment of hepatoma and pharmaceutical compositions for use therein
EP0851759A4 (en) Compounds and methods
PL321201A1 (en) Derivatives of 4-hydroxypiepridine, method of obtaining them and therapeutic agents containing such derivatives
IL119816A0 (en) Absorbent structure and method for its manufacture
NZ300198A (en) Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines
PL337513A1 (en) Novel method of obtaining pharmaceutically active compounds and their associated intermediate products
EP0959887A4 (en) Pharmaceutically active compounds and methods of use
AU2992295A (en) Therapeutic method and compounds of use therein
PL302250A1 (en) Purified form of streptogramines, method of obtaining same and pharmaceutical agents containing it
EP1041986A4 (en) Pharmaceutically active compound and methods of use
AU3261595A (en) Method of obtaining dna-rich active products